TrialDrug design, development and therapy2018

Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study.

Kwang-Hee Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.